Live investor webinar
Amplia Therapeutics Limited Investor Briefing 30 July, 11:00 AM AEST
00
days
:
00
hrs
:
00
min
:
00
sec

Clearview Wealth Ltd Sets Conditional $0.05 Dividend Ahead of Zurich Scheme Vote

By Josua Ferreira -
  • ClearView's Board has declared a fully franked Special Dividend of $0.05 per share, conditional on the Zurich scheme becoming Effective, reducing the Scheme Consideration from $0.65 to $0.60 per share.
  • Eligible shareholders who can utilise franking credits may receive total effective value of approximately $0.67 per share, comprising the $0.60 reduced Scheme Consideration, the $0.05 dividend, and up to $0.0214 in franking credits.
  • The Scheme Meeting is scheduled for 27 July 2026, with Crescent Capital Partners — holding 53.0% of shares — already committed in writing to vote in favour.
  • APRA approval has already been secured, leaving only the shareholder vote and Court sanction as the remaining conditions before full scheme implementation.
  • The Special Dividend Record Date is 5 August 2026 and the Payment Date is 12 August 2026, both conditional on the Scheme becoming Effective.

ClearView locks in fully franked $0.05 Special Dividend ahead of Zurich scheme vote

The Board of ClearView Wealth Limited (ASX: CVW) has determined to pay a fully franked Special Dividend of $0.05 per share, conditional on the proposed Zurich scheme becoming Effective.

The dividend relates to the proposed acquisition of ClearView by Zurich Financial Services Australia Limited via a members’ scheme of arrangement, announced on 24 February 2026.

If the Special Dividend is paid, the Scheme Consideration reduces from $0.65 to $0.60 per share. However, for eligible shareholders, total value including franking credits may reach approximately $0.67 per share.

What the Special Dividend means for shareholders

Under the Scheme Implementation Deed, ClearView is permitted to pay Permitted Dividends of up to $0.05 (in aggregate) per share before the Scheme is implemented, each of which may be fully franked. The Board has now committed to the full $0.05 in the form of a Special Dividend.

The payment remains conditional. It will only be made if the Scheme becomes Effective, with shareholders registered on the ClearView Share Register as at the Special Dividend Record Date entitled to receive it.

Should the Scheme become Effective and the dividend be paid, the Scheme Consideration steps down by the corresponding $0.05, while eligible shareholders may also realise the benefit of up to $0.0214 of franking credits per share.

Component Value per Share Detail
Original Scheme Consideration $0.65 Before dividend
Special Dividend (fully franked) $0.05 Conditional on Scheme becoming Effective
Reduced Scheme Consideration $0.60 After dividend paid
Potential franking credit value up to $0.0214 For eligible shareholders
Potential total value up to ~$0.67 Consideration + dividend + franking credits

The key dates for the Special Dividend are as follows:

  • Special Dividend Record Date: 7:00pm (Sydney time), Wednesday 5 August 2026

  • Special Dividend Payment Date: Wednesday 12 August 2026

Both dates are currently expected and remain conditional on the Scheme becoming Effective.

Understanding franking credits and scheme dividends

Any potential entitlement to a tax offset in respect of the franking credits attached to the Special Dividend, and therefore whether those franking credits will be of benefit, depends on the individual circumstances of each shareholder.

This matters because the potential $0.0214 franking credit value can lift the total effective value above the headline $0.60 reduced Scheme Consideration. For some shareholders, that combined value may reach approximately $0.67 per share.

The benefit is not uniform. Whether franking credits are of value to any individual shareholder depends on their own tax position. ClearView has applied to the Australian Taxation Office (ATO) for a Class Ruling to confirm the Australian income tax treatment of the Scheme and the Special Dividend.

The Class Ruling is expected to be issued by the ATO after implementation of the Scheme, rather than before. ClearView has stated it has no reason to expect the ruling will be inconsistent with the positions taken in its application, though it has not yet been issued.

ClearView has advised that shareholders should seek independent professional taxation advice regarding these matters, including when assessing the benefit of any franking credits as part of their overall consideration of the Scheme.

Scheme vote, director backing and major shareholder support

The Scheme Meeting, at which shareholders will vote on the Scheme, will be held as a hybrid meeting at 10:00am (Sydney time) on Monday, 27 July 2026. Proxy appointments can be lodged up until 10:00am (Sydney time) on Saturday, 25 July 2026.

The ClearView Directors continue to unanimously recommend that shareholders vote in favour of the Scheme. This recommendation is made in the absence of a Superior Proposal and subject to the Independent Expert continuing to conclude that the Scheme is in the best interests of shareholders.

The ClearView Directors continue to unanimously recommend that ClearView Shareholders vote in favour of the Scheme at the Scheme Meeting, in the absence of a Superior Proposal and subject to the Independent Expert continuing to conclude that the Scheme is in the best interests of ClearView Shareholders.

Support extends to the company’s largest shareholder group. Crescent Capital Partners, which holds or controls the voting rights attached to 53.0% of the shares on issue, has informed the Board in writing that it continues to intend to vote in favour of the Scheme.

APRA approval for the Zurich takeover was secured under the Financial Sector (Shareholdings) Act 1998, satisfying one of the final regulatory conditions precedent and leaving only the shareholder vote and Court sanction standing between ClearView and full scheme implementation.

That intention is subject to the same qualifications applying to the Directors’ recommendation, namely the continued unanimous board recommendation, the Independent Expert’s ongoing conclusion, and there being no superior proposal.

What happens next for ClearView investors

The pathway ahead follows a defined sequence. Shareholders vote at the Scheme Meeting on 27 July 2026. If the Scheme is approved and subsequently becomes Effective, the Dividend Record Date falls on 5 August 2026, with payment expected on 12 August 2026.

Critical Path Timeline for ClearView Shareholders

ACCC phase 1 clearance was granted in May 2026, resolving the most uncertain regulatory variable in the deal and narrowing the remaining conditions precedent to APRA sign-off, shareholder approval, and Court sanction.

Crescent Capital Partners’ support statement was made on the assumption that the Scheme will be implemented on or before 24 February 2027.

Shareholders can find detailed information in the Scheme Booklet, which was despatched on 26 June 2026. Further queries can be directed to the ClearView Shareholder Information Line on 1300 948 609 within Australia.

The decision facing shareholders is clearly framed. There is a defined value pathway of up to approximately $0.67 per share including potential franking benefits, backed by unanimous board support and the stated intention of a majority shareholder to vote in favour, all remaining subject to the vote and the conditions of the Scheme.

Stay Ahead on ASX Finance and Fintech News

Breaking ASX announcements like this one land in your inbox within minutes with Big News Blast, completely FREE and with in-depth analysis already done. Over 20,000+ active subscribers rely on it to stay ahead of market-moving news across finance, fintech, and beyond. Click the “Free Alerts” button at StockWire X to start receiving alerts the moment news breaks.


Frequently Asked Questions

What is the ClearView Wealth Special Dividend and how does it relate to the Zurich acquisition?

ClearView's Board has declared a fully franked Special Dividend of $0.05 per share, payable only if the proposed Zurich scheme becomes Effective. When paid, the Scheme Consideration reduces from $0.65 to $0.60 per share, but eligible shareholders may receive total value of approximately $0.67 per share including franking credits.

When will ClearView shareholders vote on the Zurich scheme?

The Scheme Meeting is scheduled for 10:00am Sydney time on Monday 27 July 2026, with proxy appointments accepted until 10:00am on Saturday 25 July 2026.

How do franking credits affect the total value ClearView shareholders receive?

Eligible shareholders can receive up to $0.0214 in franking credits per share attached to the Special Dividend, which can lift the total effective value from $0.60 to approximately $0.67 per share — though the benefit depends on each shareholder's individual tax position.

What regulatory approvals has the Zurich takeover of ClearView already received?

Both ACCC phase 1 clearance (granted May 2026) and APRA approval under the Financial Sector (Shareholdings) Act 1998 have been secured, leaving only the shareholder vote and Court sanction as the remaining conditions before the scheme can be implemented.

What is the Special Dividend payment date for ClearView shareholders?

The Special Dividend Record Date is 5 August 2026 at 7:00pm Sydney time, with the payment expected on 12 August 2026 — both dates are conditional on the Scheme becoming Effective following the 27 July shareholder vote.

Josua Ferreira
By Josua Ferreira
Partnership Director
Josua Ferreira holds a Bachelor of Commerce in Marketing and Advertising and brings a background in publication, business development, and ASX market storytelling. He has worked with listed companies across the resource sector and broader market, combining sharp commercial instincts with a genuine commitment to keeping investors informed.
Learn More
Companies Mentioned in Article

Breaking ASX Alerts Direct to Your Inbox

Join +20,000 subscribers receiving alerts.

Join thousands of investors who rely on StockWire X for timely, accurate market intelligence.

About the Publisher